Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for October 2009
October 1, 2009
- FDA Issues Draft Guidance on Risk Evaluation and Mitigation Strategies
- Fovea Pharmaceuticals to be Acquired by sanofi-aventis
- Pfizer Receives Approval From Australian Competition And Consumer Commission (ACCC) For Pending Acquisition Of Wyeth
- Repros Therapeutics Inc. Provides Update on Proellex
- Sanofi-aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM-121, an Anti-ErbB3 Monoclonal Antibody
- Sanofi-Aventis to Buy Abingworth Portfolio Company Fovea
- MarkMonitor Finds Online Drug Brand Abuse is Growing
- FDA Warning Letters Caused Dramatic Decline in Sponsored Link Exposures, According to comScore
- FDA Alert: New USP Standards for Heparin Products Will Result in Decreased Potency
October 2, 2009
- Allergan Files Federal Lawsuit to Allow It to Share Relevant Information with the Medical Community on the Safe Use of Botox for Common Therapeutic Off-Label Treatments
- Avexa Closes ATC's Phase III Trial to Evaluate Data
- Baxter Receives EMEA Positive Opinion for CELVAPAN H1N1 Pandemic Influenza Vaccine
- Jeffrey B. Kindler and James S. Tisch to Join New York Fed Board of Directors
- Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro (escitalopram oxalate) ANDA Patent Litigation
October 5, 2009
- Seattle Genetics Announces Discontinuation of Dacetuzumab Phase IIb Diffuse Large B-Cell Lymphoma Clinical Trial
- Pharmaceutical Companies Rebrand Speaker Programs to Meet Changing Political and Regulatory Landscape, Says New Study by Cutting Edge Information
- SEC Closes Investigation of PharmaNet Development Group and Recommends No Action
- Daiichi Sankyo to Leverage Ranbaxy's Presence in Mexico for Marketing and Distribution
- Physician Smartphone Adoption Rate to Reach 81% in 2012
- License to Market Kremezin (drug for chronic renal failure) in Japan
- CombinatoRx-Derived Combination Drug Candidate, Prednisporin, Acquired by Sanofi-Aventis Through Proposed Acquisition of Fovea Pharmaceuticals
- Phase 2 Trial Of Rp101 In Late-Stage Pancreatic Cancer Discontinued
- In the battle against cancer, ?future progress depends on personalisation of healthcare? says AstraZeneca Chief Executive
October 6, 2009
- ?Pre-Visit Patients? Emerge as New Segment for Advertisers
- Hydrogen Advertising Teams Up with Local Chapter of National Multiple Sclerosis Society
October 7, 2009
- Impax Laboratories Settles Pending Litigation for Flomax
- Health 2.0 on the Rise - 35% of U.S. Adults Use Social Media for Medical Information
October 8, 2009
- Novartis Gains Exclusive Worldwide Rights to PTK 0796, in Phase III Study as Potential First-in-Class IV and Oral Broad-Spectrum Antibiotic
- IMS Health Forecasts Global Pharmaceutical Market Growth of 4 - 6 Percent in 2010; Predicts 4 - 7 Percent Expansion Through 2013
- Cancer Drugs Emerging as Top Driver of Specialty Drug Spending
October 9, 2009
- GlaxoSmithKline and U.S. Patent and Trademark Office File a Motion to Dismiss Litigation Over Final Regulations
- Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for FUSILEV in Advanced Metastatic Colorectal Cancer
- Vaccinating Boys Against Human Papillomavirus Not Cost-Effective
- ReachMD XM 160 Announces Two New Radio Programming Series - Featuring the New England Journal of Medicine
October 11, 2009
October 12, 2009
October 13, 2009
- Johnson & Johnson Reports 2009 Third-Quarter Results:
- Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt, an FDA-Approved Oral Therapy for Schizophrenia
- Prosensa and GlaxoSmithKline Form Alliance to Fight Duchenne Muscular Dystrophy
- Medafor Selects AllOut Marketing as Medical Marketing Partner
- Shire and Sandoz Settle all Pending Litigation Concerning Adderall XR
- PhRMA Statement on Senate Finance Committee Vote
October 14, 2009
- FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets
- Dainippon Sumitomo Pharma Co., Ltd. and Sepracor Inc. Announce Successful Tender Offer and Commencement of Subsequent Offering Period
- Acorda Therapeutics Stock Trading Halted Today; FDA Advisory Committee to Review Fampridine-SR for Improvement of Walking Ability in People with Multiple Sclerosis
- Elan Corporation PLC Announces Results to Date of Tender Offer for 7¾% Senior Fixed Rate Notes Due 2011
- Pfizer Announces Settlement And License Agreement With Mylan Related To Vfend
- Abbott Reports 16.5 Percent Earnings Growth in Third Quarter; Raises Earnings Guidance for 2009
- Galapagos Expands Strategic Alliance in Metabolic Disease with Merck & Co., Inc.
- CSL Donates 3 Million Doses of Pandemic H1N1 2009 Vaccine to the World Health Organisation (WHO) for Use in Low-Income Countries in this Region
- Sample Accountability Shows Stepped-Up Focus
October 15, 2009
- New FDA Web Page Lists Disposal Instructions for Select Medicines
- Baxter Reports Double-Digit EPS Growth for Third Quarter 2009
- La Jolla Pharmaceutical Company to Seek Stockholder Approval of Dissolution
- Roche reports further accelerated sales growth in third quarter
- Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax Sprinkle Capsules
- Interpublic Aligns Deutsch Inc. and Lowe Worldwide
- Loomis Group Health, Capella Advisors Form Strategic Partnership to Guide Healthcare Companies from Clinical Trials to Marketplace
- comScore Study Finds the Internet a Key Component in Consumer Research on Prescriptions and Health Conditions
- Pfizer Completes Acquisition Of Wyeth
October 16, 2009
- AstraZeneca Submits Marketing Authorisation Application to European Union for Vimovo
- Kentucky Attorney General Conway Announces $14.7 Million Verdict Against Drug Company
- Court Imposes Record Fine and Forfeiture of $1.3 Billion for Pharmacia & Upjohn Company's Fraudulent Marketing of Bextra
October 20, 2009
October 21, 2009
- Sanofi-Aventis and Wellstat Therapeutics Enter into an Exclusive Worldwide Licensing Agreement for Novel Oral Agent to Treat Type II Diabetes
- FDA Sends Warning Letter to King Pharmaceuticals Over Embeda Videos
- Genzyme Reports Third-Quarter Financial Results
- Account Win for Centron
October 22, 2009
- IMS Health Announces 2009 Third-Quarter Results
- Merck Announces Third-Quarter 2009 Financial Results
- Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in Third Quarter
- Centron Wins Agency Of Record Assignments From Strativa
- Schering-Plough Reports Financial Results for 2009 Third Quarter
- Novartis delivers strong new product momentum and operational performance in first nine months of 2009
- Amgen's Third Quarter 2009 Adjusted Earnings Per Share Increased 21 Percent to $1.49
- GE and Lilly Achieve Significant Advancement in Cancer Research
- Angela Cole Joins Lyonheart As Executive Vice President, Director Of Client Services
October 23, 2009
- Merck and Schering-Plough Receive Approval From European Commission for Merger
- Rituxan (rituximab) - Third case of PML reported, the first case of PML in a patient with rheumatoid arthritis treated with Rituxan who has not previously received treatment with a TNF antagonist
October 24, 2009
October 26, 2009
- Q3/2009: Merck KGaA Revenues Increase by 2.7% to ? 1.9 Billion
- S&R Communications Group Reengineers Into S+R Medical Communications And Friday Morning
- Blue Spoon Consulting Publishes Strategy Innovation for Established Drug Brands
- Grassley Says Drug Companies Should Disclose Payments, Seeks Greater Transparency
October 27, 2009
- Bayer back on the uptrend
- Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer
- Changing Behavior Helps Patients Take Medication as Prescribed
- Vertiyo Creative Services Launches Pharma Division
- Vertiyo Creative Group Announces Vertiyo Health, New Unit Focused on Pharmaceutical Marketing
October 28, 2009
- Neurobiological Technologies Announces Stockholder Approval of Plan of Liquidation and Dissolution
- FDA Sends Letter to Sanofi-Aventis Regarding Uroxatral Promotion
- GSK delivers Q3 EPS of 28.5p before major restructuring and dividend of 15p up 7%
- Use of Antipsychotic Medications by Children and Adolescents Associated With Significant Weight Gain
- HealthCentral partners with online video startup to create largest health video network
October 29, 2009
- Alcon Posts 5.9 Percent Sales Growth for Third Quarter
- P&G First Quarter Sales and EPS Exceed Expectations
- AstraZeneca: Third Quarter and Nine Months Results 2009
- Mylan Reports Third Quarter Adjusted Diluted EPS of $0.32
- Allergan Reports Third Quarter 2009 Operating Results
- AstraZeneca PLC Third Quarter & Nine Months Results 2009
- Novo Nordisk Interim Financial Report for nine months ending 30 September 2009
October 30, 2009
- Pfizer's Board Of Directors Approves Shareholder Advisory Vote On Executive Compensation
- Sanofi-aventis Delivers a Solid Performance in Third Quarter 2009
- Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates
- Geron and FDA Reach Agreement on Clinical Hold
- States file kickback lawsuit against biotech giant Amgen
